FOLH1 and prostate cancer: A prominent example of a prostate cancer associated antigen is the prostate-specific membrane antigen (PSMA), which is expressed in almost all prostate cancer cells, from primary to metastatic disease, and has been used as a target for the development of both radioisotope and chemo-conjugated antibodies [5,6].